Treat identity, testing, provenance and clinical evidence as separate questions rather than one reassuring story.
A label identifies what a product is presented as containing. It does not by itself establish that its identity, amount or production have been independently assessed. The FDA describes contamination and incorrect active-ingredient amounts as examples of quality problems arising from poor compounding practices. That context helps explain why the product question matters separately from the research question. Familiar terminology and professional presentation cannot replace information about the concrete product.
An analytical report needs context: which sample was tested, when, by whom and for which question? A result is only interpretable within the scope of that method and sample. One favourable measurement does not answer every other quality question. Read the report as a bounded observation rather than a general endorsement. This guide helps identify the limits of information; it does not provide a method for declaring an unassessed item suitable for treatment.
Preparing the full guide…
The extended sections are available during your one-minute preview and with free email registration.
- Identity, amount and clinical benefit are different claims
- Read provenance as an information question
- Regulatory context is part of the product story
- A professional website can still leave gaps
- Questions for an independent discussion
- Draw two separate conclusions
Sources & further reading
Sources support specific statements, not every possible use of a molecule. Echo hub articles provide research background; original publications and official guidance are identified where supplied.